Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | MAOA | P21397 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | GSK3B | P49841 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4078022 | 0.90 | CA2 (0.58) | TSHRCA2MAOBCA1ALDH1A1 | |
| SCHEMBL2178959 | 0.90 | MAOB (0.50) | TSHRCA2MAOBCA1ALDH1A1 | |
| SCHEMBL21783604 | 0.86 | TSHR (0.59) | TSHRCA2MAOBCA1ALDH1A1 | |
| SCHEMBL21783558 | 0.86 | TSHR (0.59) | TSHRCA2MAOBCA1ALDH1A1 | |
| SCHEMBL21783611 | 0.86 | TSHR (0.59) | TSHRCA2MAOBCA1ALDH1A1 | |
| SCHEMBL23456757 | 0.86 | TSHR (0.59) | TSHRCA2MAOBCA1ALDH1A1 | |
| SCHEMBL7069395 | 0.82 | TSHR (0.61) | TSHRCA2CA1ALDH1A1L3MBTL1 | |
| SCHEMBL4357019 | 0.82 | TSHR (0.54) | TSHRCA2MAOBCA1ALDH1A1 | |
| SCHEMBL10606109 | 0.82 | TSHR (0.54) | TSHRCA2MAOBCA1ALDH1A1 | |
| SCHEMBL6413833 | 0.82 | CES2 (0.65) | TSHRCA2CA1ALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130172529-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES S.A. (ES) | 2013-07-04 | — | — | US | disclosed |
| EP-2019118-B1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES SA (ES) | 2012-11-07 | — | — | EP | disclosed |
| US-20110166071-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES S.A. (ES) | 2011-07-07 | — | — | US | disclosed |
| US-20100075924-A1 | DUTPASE INHIBITORS | MEDIVIR AB (SE) | 2010-03-25 | — | — | US | disclosed |
| US-7601702-B2 | Dutpase Inhibitors | MEDIVIR AB (SE) | 2009-10-13 | — | — | US | disclosed |
| EP-2019118-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN Peptides, S.A. (ES) | 2009-01-28 | — | — | EP | disclosed |
| US-20080300216-A1 | Dutpase Inhibitors | MEDIVIR AB (SE) | 2008-12-04 | — | — | US | disclosed |
| WO-2007132037-A1 | METHOD FOR SYNTHESIZING THYMOSINS | BCN PEPTIDES, S.A. (ES) | 2007-11-22 | — | — | WO | disclosed |
| WO-2003046582-A2 | CANCER PROGNOSIS USING THYMOSIN β10 (Tβ10) | NATIONAL CENTER FOR SCIENTIFIC RESEARCH 'DEMOKRITOS' (GR) | 2003-06-05 | — | — | WO | disclosed |
| EP-0609058-B1 | Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses | SANKYO CO (JP) | 1998-12-09 | — | — | EP | disclosed |
| US-5827855-A | ANTICHOLESTEROL AGENTS TREATING CARDIOVASCULAR DISORDERS; ENZYME INHIBITORS | SANKYO COMPANY, LIMITED (JP) | 1998-10-27 | — | — | US | disclosed |
| US-5792840-A | SUBSTITUTED GLUCOPYRANOSYL PHOSPHATES | SANKYO COMPANY, LIMITED (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0605230-B1 | Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses | SANKYO CO (JP) | 1997-08-27 | — | — | EP | disclosed |
| EP-0437016-B1 | Lipid A analogues having immunoactivating and anti-tumour activity | SANKYO CO (JP) | 1996-05-01 | — | — | EP | disclosed |
| US-5491167-A | INHIBITORS OF CHOLESTEROL BIOSYNTHESIS | SANKYO COMPANY, LIMITED (JP) | 1996-02-13 | — | — | US | disclosed |
| US-5451688-A | Inhibit biosynthesis of cholesterol | SANKYO COMPANY, LIMITED (JP) | 1995-09-19 | — | — | US | disclosed |
| EP-0609058-A2 | Hexahydronaphthalene ester derivatives, their preparation and their therapeutic uses | SANKYO COMPANY LIMITED (JP) | 1994-08-03 | — | — | EP | disclosed |
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166071-A1 | METHOD FOR SYNTHESIZING THYMOSINS | PTMS, PTMA, VIP | TSHR 152/4885CA2 3762/4885MAOB 3975/4885 |
| US-20080300216-A1 | Dutpase Inhibitors | DUT, DHODH, POLR2H | TSHR 2353/4885CA2 3008/4885MAOB 540/4885 |
| US-20130172529-A1 | METHOD FOR SYNTHESIZING THYMOSINS | PTMS, PTMA, VIP | TSHR 152/4885CA2 3762/4885MAOB 3975/4885 |
| US-20100075924-A1 | DUTPASE INHIBITORS | DUT, DHODH, CCNO | TSHR 2414/4885CA2 3019/4885MAOB 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.